135 related articles for article (PubMed ID: 37751774)
1. ABO Blood Group and the Risk of Thrombosis in Cancer Patients: A Mini-Review.
Elsherif S; Zidan A; Saville O; Othman M
Semin Thromb Hemost; 2024 Apr; 50(3):423-428. PubMed ID: 37751774
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group and thrombotic vascular disease.
Franchini M; Mannucci PM
Thromb Haemost; 2014 Dec; 112(6):1103-9. PubMed ID: 25187297
[TBL] [Abstract][Full Text] [Related]
3. ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.
Ibrahim-Kosta M; Bailly P; Silvy M; Saut N; Suchon P; Morange PE; Chiaroni J; Trégouët DA; Goumidi L
Thromb Res; 2020 Sep; 193():31-35. PubMed ID: 32505996
[TBL] [Abstract][Full Text] [Related]
4. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
5. ABO blood group as a potential risk factor for venous thromboembolism in acutely injured patients.
Muellner SK; Haut ER; Streiff MB; Holcomb JB; Cotton BA
Thromb Haemost; 2011 Jan; 105(1):5-13. PubMed ID: 21103665
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications.
Calabrò P; Gragnano F; Golia E; Grove EL
Semin Thromb Hemost; 2018 Apr; 44(3):249-260. PubMed ID: 28898897
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
[TBL] [Abstract][Full Text] [Related]
8. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
[TBL] [Abstract][Full Text] [Related]
9. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
[TBL] [Abstract][Full Text] [Related]
10. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.
Ward SE; O'Sullivan JM; O'Donnell JS
Blood; 2020 Dec; 136(25):2864-2874. PubMed ID: 32785650
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
[TBL] [Abstract][Full Text] [Related]
12. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.
Wu O; Bayoumi N; Vickers MA; Clark P
J Thromb Haemost; 2008 Jan; 6(1):62-9. PubMed ID: 17973651
[TBL] [Abstract][Full Text] [Related]
13. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins PV; O'Donnell JS
Transfusion; 2006 Oct; 46(10):1836-44. PubMed ID: 17002642
[TBL] [Abstract][Full Text] [Related]
14. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.
Dentali F; Sironi AP; Ageno W; Turato S; Bonfanti C; Frattini F; Crestani S; Franchini M
Semin Thromb Hemost; 2012 Jul; 38(5):535-48. PubMed ID: 22740183
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
16. High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.
Payne AB; Miller CH; Hooper WC; Lally C; Austin HD
Ethn Dis; 2014; 24(2):169-74. PubMed ID: 24804362
[TBL] [Abstract][Full Text] [Related]
17. ABO blood group type and risk of venous thromboembolism in patients with cancer.
Englisch C; Moik F; Nopp S; Raderer M; Pabinger I; Ay C
Blood Adv; 2022 Dec; 6(24):6274-6281. PubMed ID: 35416922
[TBL] [Abstract][Full Text] [Related]
18. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
Bhanvadia S; Kazerouni K; Bazargani ST; Miranda G; Cai J; Daneshmand S; Djaladat H
World J Urol; 2019 Jan; 37(1):173-179. PubMed ID: 29876671
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
20. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
